The Ergo-Series maximises ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures. Credit: Sight Sciences, Inc.

Eyecare technology company Sight Sciences has introduced the Ergo-Series of its OMNI Surgical System in the US.

The new technology allows surgeons to perform minimally invasive, implant-free glaucoma procedures to reduce intraocular pressure (IOP) in primary open-angle glaucoma adult patients.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Sight Sciences stated that the OMNI Surgical System enables a minimally invasive glaucoma surgery (MIGS) that helps address three known resistance points in the aqueous outflow system, namely Schlemm’s canal, the trabecular meshwork and the collector channels.

The Ergo-Series’ new features include improved handle ergonomics, simplified viscoelastic preparation and a new cannula tip design.

With the improved handle ergonomics, surgeons will be able to rotate and position the cannula tip more easily in the Schlemm’s canal, using accurate finger rotations instead of wrist adjustments.

Meanwhile, the new cannula tip design enables gentle and precise access to Schlemm’s canal.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Sight Sciences CEO and co-founder Paul Badawi said: “OMNI is an innovative technology developed to enable a surgeon to perform a circumferential and complete outflow procedure that addresses all three known points of resistance in the aqueous outflow system through a single clear corneal incision.

“We are committed to continually innovating and improving our core technologies alongside our surgeon partners in order to provide the greatest benefit to patients suffering from primary open-angle glaucoma.”

The OMNI Surgical System is indicated for canaloplasty (microcatheterisation and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork).

It can also be used in conjunction with or after cataract surgery.

Sight Sciences expects to launch the Ergo-Series of the OMNI Surgical System outside the US later in the year.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact